Post Profile






See more about: Osiris Therapeutics

Related Posts


Osiris Therapeutics Announces First Quarter 2013 Financial Results

Business & Finance / Personal Finance : Savings Experiment

Osiris Therapeutics Announces First Quarter 2013 Financial Results COLUMBIA, Md.--(BUSINESS WIRE)-- Osiris Therapeutics, Inc. ( NAS: OSIR ), the leading stem cell company focused on developing and marketing products to treat medical...

Market Close: Today's Big Winners & Losers (OSIR, END, APP, HCI, PTEK, RDIB, MELA, OPXA, ACUR, RWC)

Business & Finance / Personal Finance : Savings Experiment

Here are today's five biggest gaining stocks at closing: Osiris Therapeutics Inc.. (NASDAQ: OSIR) is up 35.2% at $9.34. Endeavor International Corp. (NYSE: END) is up 28.8% at $3.53. American Apparel Inc. (NYSEMKT: APP) is up 22.2% ...

Osiris Therapeutics, Inc. (OSIR), Anacor Pharmaceuticals Inc (ANAC), Novavax, Inc. (NVAX): Three Humongous Health-Care Stocks This Week

Business & Finance / Investing : Insider Monkey

A rising tide lifts all boats, but the opposite isn’t true in the stock market. The major indexes slipped this week, while a handful of health-care stocks soared. Here are three humongous performers over the last week. Double play (...

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN), Alexion Pharmaceuticals, Inc. (ALXN): Biotech’s Falling Fortunes Stymie Osiris Therapeutics, Inc. (OSIR)’s Huge Week

Business & Finance / Investing : Insider Monkey

Biotech’s the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts. The industry had a rough week as a whole, as the Na...

Osiris Therapeutics Completes Enrollment Of Stem Cell Trial For The Treatment Of Heart Attacks

Health : Medical News Today

Osiris Therapeutics, Inc. (NASDAQ: OSIR), announced that it has successfully completed enrollment in a Phase 2 clinical trial evaluating Prochymal (remestemcel-L), an adult mesenchymal stem cell therapy, in patients experiencing the...

Comments


Copyright © 2016 Regator, LLC